Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice, 53702 [2010-21800]

Download as PDF 53702 Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices Period of Replacement Award: The period of support for the replacement award is June 1, 2010 to October 31, 2010. Authority: Section 330(h) of the Public Health Service Act, 42 U.S.C. 245b. CDFA Number: 93.703. Justification for Exception to Competition: The former grantee, Saint Vincent’s Catholic Medical Centers of New York, has relinquished all grants. Saint Vincent’s Catholic Medical Centers of New York’s inpatient services has closed, and Saint Vincent’s Catholic Medical Center of New York has filed for bankruptcy under Chapter 11. The former grantee has requested that HRSA transfer the Health Center Program Section 330(h) funds to SPHC in order to implement and carry out grant activities originally proposed under SVCMC funded Section 330(h) grant applications. SPHC has been engaged in the delivery of primary health care services in the local area and is a current Section 330 grantee who indicated an ability to assume operations without a disruption of services. The short-term transfer of the 330(h) funds will ensure that critical primary health care services continue and remain available to low-income, underserved, homeless patients with no interruption in services to the target population. FOR FURTHER INFORMATION CONTACT: BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2010–N–0389] Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice hsrobinson on DSK69SOYB1PROD with NOTICES Food and Drug Administration, HHS. Notice. The Food and Drug Administration (FDA) is announcing an amendment to the notice of a public meeting on the reauthorization of the medical device user fee program. This meeting was announced in the Federal SUMMARY: 18:24 Aug 31, 2010 BILLING CODE 4160–01–S National Institute of Mental Health; Amended Notice of Meeting [FR Doc. 2010–21836 Filed 8–31–10; 8:45 am] VerDate Mar<15>2010 [FR Doc. 2010–21800 Filed 8–31–10; 8:45 am] National Institutes of Health Dated: August 26, 2010. Mary K. Wakefield, Administrator. ACTION: Dated: August 27, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. DEPARTMENT OF HEALTH AND HUMAN SERVICES Marquita Cullom-Scott via e-mail at MCullom-Scott@hrsa.gov or 301–594– 4300. AGENCY: Register of August 13, 2010 (75 FR 49502). The amendment is being made to include the exact meeting location, previously identified only as the Washington D.C. metropolitan area. There are no other changes. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993, 301–796–6313, FAX: 301– 847–8121, email: James.Swink@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In the Federal Register of August 13, 2010 (75 FR 49502), FDA announced that a public meeting on the reauthorization of the medical device user fee program would be held on September 14, 2010. On page 49503, in the first column, the Location portion of the document is changed to read as follows: Location: The meeting will be held at the Marriott Inn and Conference Center, University of Maryland University College (UMUC), 3501 University Blvd. East, Hyattsville, MD 20783, www.marriott.com/wasum. Jkt 220001 Notice is hereby given of a change in the meeting of the Services Subcommittee of the Interagency Autism Coordinating Committee (IACC), September 13, 2010, 1 p.m. to 4 p.m., National Institute of Mental Health, Neuroscience Center, 6001 Executive Boulevard, Conference Room A1/A2, Rockville, MD 20852, which was published in the Federal Register on August 19, 2010, 75 FR 51276. The meeting will not be Webcast as originally advertised. The meeting is open to the public and will still be accessible through a conference call phone number. The meeting will be held in the same place and same time. Dated: August 25, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21817 Filed 8–31–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Neuroscience and Neurodegeneration Study Section, September 30, 2010, 8 a.m. to October 1, 2010, 5 p.m., Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC, 20005 which was published in the Federal Register on August 4, 2010, 75 FR 46950–46951. The meeting will be one day only September 30, 2010. The meeting time and location remain the same. The meeting is closed to the public. Dated: August 26, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–21816 Filed 8–31–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Developmental Biology. Date: September 14–15, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Noni Byrnes, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435– 1023, byrnesn@csr.nih.gov. E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Page 53702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21800]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2010-N-0389]


Medical Device User Fee Act; Public Meeting; Request for 
Comments; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of a public meeting on the reauthorization of 
the medical device user fee program. This meeting was announced in the 
Federal Register of August 13, 2010 (75 FR 49502). The amendment is 
being made to include the exact meeting location, previously identified 
only as the Washington D.C. metropolitan area. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT:  James Swink, Center for Devices and 
Radiological Health, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993, 301-796-6313, FAX: 
301-847-8121, email: James.Swink@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:  In the Federal Register of August 13, 2010 
(75 FR 49502), FDA announced that a public meeting on the 
reauthorization of the medical device user fee program would be held on 
September 14, 2010. On page 49503, in the first column, the Location 
portion of the document is changed to read as follows:
    Location: The meeting will be held at the Marriott Inn and 
Conference Center, University of Maryland University College (UMUC), 
3501 University Blvd. East, Hyattsville, MD 20783, www.marriott.com/wasum.

    Dated: August 27, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-21800 Filed 8-31-10; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.